XTAE
QLTU
Market cap475mUSD
Oct 09, Last price
32,160.00ILS
1D
3.54%
1Q
-35.21%
Jan 2017
4,962.97%
IPO
1,815.43%
Name
Qualitau Ltd
Chart & performance
P/E
23.96
P/S
8.44
EPS
4.40
Div yield, %
4.92%
Shrs. gr., 5y
1.54%
Rev. gr., 5y
22.16%
Revenues
61m
+32.46%
Net income
22m
+55.13%
CFO
7m
-57.06%
Dividend
Sep 04, 2026184.10522 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Qualitau Ltd. operates globally within the semiconductor sector, specializing in the development, manufacturing, and distribution of sophisticated testing equipment and related services. The company's product portfolio features a variety of reliability test systems, offering multi-application testing for both packaged devices and wafers, as well as pulse EM and BTS testing at the package level, and TDDB and HC testing for both packages and wafers. Additionally, Qualitau provides multi-site parallel wafer-level probing systems and semi-automatic probers. Its comprehensive parametric and reliability solutions include desktop semiconductor parametric testers, fully automated multiplexers for streamlined wafer probing and testing, and micro-oven systems. Beyond hardware, Qualitau delivers expert reliability test services for both package and wafer levels. Founded in 1994, the company is headquartered in Ness Ziona, Israel.
Key people
Jacob Herschmann
President · since 1988
Gdaliahoo Krieger
Chairman of the Board, Chief Executive Officer · since 1996
Nava Ben-Yehuda
Chief Financial Officer · since 2004
Jose Yasagari
Chief Technology Officer · since 2000
Nir Dery
Director · since 2017
Betzalel Iger
Director · since 2017
Pazy Landshtain
Director · since 2011
Director · since 2017
External Director · since 2018
Carmela Gonen
External Director · since 2006
External Director · since 2017
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||